Code | 32330 | ||||||||||
MA number | EU/1/03/271/007 | ||||||||||
Product Form: | plv iol 1x250 IU+1x2 ml solv. (liek.inj.skl.+liek.inj.skl.+ pom.na rekonšt.) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
Therapeutic Class: | 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - known active substance |
MA issued: | 02.03.2004 |
SmPC + PL: | European Medicines Agency's database |
Dokument: | DHPC_BAXJECT II_BAXJECT II Hi-Flow_10.08.2023.pdf |
Safety feature | Yes |
Data update: | 07.12.2021 |